Survey Finds Few Know about Advances in HIV Prevention and Treatment; Stigma and Misperceptions Persist MENLO PARK, CA –(ENEWSPF)—December 1, 2017. A comprehensive new national survey of young adults, ages 18-30, from the Kaiser Family Foundation finds more than three and half decades into the epidemic, HIV remains an issue of deep[Read More…]
Health and Fitness
Congresswoman Robin Kelly Marks World AIDS Day by Promoting Testing
Washington, DC—(ENEWSPF)—December 1, 2017 By: James Lewis [email protected] Today, Congresswoman Robin Kelly, chair of the Congressional Black Caucus Health Braintrust, released this statement marking World AIDS Day: “The AIDS epidemic is a public health crisis that affects every American community and communities across the globe. For decades, this terrible disease[Read More…]
FDA Approves First Biosimilar for Treatment of Certain Breast and Stomach Cancers
Silver Spring, Maryland—(ENEWSPF)—December 1, 2017 By: Angela Stark The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the[Read More…]
FDA announces approval of First Breakthrough-designated Test to Detect Extensive Number of Cancer Biomarkers
Silver Spring, Maryland—(ENEWSPF)—December 1, 2017 By: Tara Rabin The U.S. Food and Drug Administration approved the FoundationOne CDx (F1CDx), the first breakthrough-designated, next generation sequencing (NGS)-based in vitro diagnostic (IVD) test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type. The Centers[Read More…]
Bipartisan Group of 66 Members of Congress Calls on Congressional Leadership to Protect State Medical Marijuana Laws
Washington, D.C. –(ENEWSPF)—November 30, 2017. Representatives Earl Blumenauer (D-OR) and Dana Rohrabacher (R-CA) led a bipartisan group of lawmakers urging House and Senate leadership to continue state medical marijuana protections in any legislation to fund the government beyond December 8, 2017. The Rohrabacher-Blumenauer provision prevents the Department of Justice from interfering with[Read More…]
Frequency of HIV Testing and Time from Infection to Diagnosis Improve
Many people still have HIV for years before they know it Atlanta, GA—(ENEWSPF)—November 28, 2017 By: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention A new CDC Vital Signs report published today finds that HIV is being diagnosed sooner after infection than was previously reported. According to the[Read More…]
FDA Approves First Implanted Lens That can be Adjusted After Cataract Surgery
Implanted lens may improve vision without eyeglasses in some patients Silver Spring, Maryland—(ENEWSPF)—November 22, 2017 By: Stephanie Caccomo The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’[Read More…]
FDA Approves First Two-drug Regimen for Certain Patients with HIV
Silver Spring, Maryland—(ENEWSPF)—November 22, 2017 By: Theresa Eisenman The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment. Juluca is[Read More…]
USDA Provides Tips and Resources for a Bacteria-Free Thanksgiving
WASHINGTON–(ENEWSPF)– November 22, 2017 — More than 45 million turkeys are eaten on Thanksgiving Day, with a never-ending list of side dishes and desserts. The Thanksgiving meal is by far the largest and most stressful meal many consumers prepare all year, leaving room for mistakes that can make guests sick.[Read More…]
FDA Approves First Telehealth Option to Program Cochlear Implants Remotely
Silver Spring, Maryland—(ENEWSPF)—November 17, 2017 By: Theresa Eisenman The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming feature is indicated for patients who have had six months of experience with their[Read More…]
